financetom
Business
financetom
/
Business
/
Global defensive sector funds see surge in inflows on slowdown fears
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Global defensive sector funds see surge in inflows on slowdown fears
Sep 17, 2024 4:36 AM

(Reuters) - Global defensive sector funds are in demand from investors as concerns about a slowdown in the U.S. economy forces them to seek assets such as consumer staples and utilities stocks that can withstand weakness in labour markets and commodities.

BY THE NUMBERS

According to LSEG Lipper data, defensive sector funds such as consumer staples and utilities attracted substantial inflows of $1.43 billion and $1.06 billion, respectively, over the last two weeks. In contrast, sectors such as technology, financials, and industrials experienced significant outflows, totalling $2.97 billion, $1.38 billion, and $540 million respectively.

Over the past month, the MSCI Consumer Staples index has seen a notable increase of 3.92%, significantly outpacing the 1.35% gain of the MSCI World index.

WHY IT'S IMPORTANT

This shift in trend could diversify the market rally, as defensive sectors such as consumer staples and healthcare were previously sidelined in favour of growth-oriented sectors such as tech and artificial intelligence.

CONTEXT

U.S. manufacturing PMIs showed factory activity continued to contract in August, while employment reports suggested the labour market cooled.

Some analysts believe that mere rate cuts may not adequately offset the decline in corporate profits or market uncertainties, if the economy is moving towards a recession.

KEY QUOTE

Since the start of September, defensive sectors have emerged as market leaders in response to increasing signs of an economic slowdown, said Rob Anderson, U.S. sector strategist at Ned Davis Rsearch.

However, he said: "If stocks rally post-election as uncertainty lifts and seasonality turns more favourable, cyclical sectors could once again gain the upper hand."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CI Financial Reports Total Assets of $511.3 Billion for July
CI Financial Reports Total Assets of $511.3 Billion for July
Aug 19, 2024
07:43 AM EDT, 08/19/2024 (MT Newswires) -- CI Financial ( CIXXF ) on Monday reported preliminary total assets of $511.3 billion at July 31, the first time its total assets have surpassed the $500-billion milestone. CI's total assets consist of asset management assets of $133.3 billion, Canadian wealth management assets of $98.2 billion, Canadian custody assets of $30.3 billion, and...
Marriott, Sonder Form Licensing Agreement; Adding an Expected 9,000 Rooms to Portfolio This Year
Marriott, Sonder Form Licensing Agreement; Adding an Expected 9,000 Rooms to Portfolio This Year
Aug 19, 2024
07:47 AM EDT, 08/19/2024 (MT Newswires) -- Marriott International ( MAR ) said Monday it has formed a long-term licensing agreement with Sonder Holdings (SOND) in a deal expected to add 9,000 rooms to its portfolio this year and 1,500 afterward. Under the agreement, Marriott ( MAR ) said it will receive royalty fees based on Sonder's room revenues. Sonder's...
Global Atomic Says Niger Government Supports Dasa Project
Global Atomic Says Niger Government Supports Dasa Project
Aug 19, 2024
07:42 AM EDT, 08/19/2024 (MT Newswires) -- Global Atomic ( GLATF ) , which lost nearly 4% on Friday, on Monday announced that the government of the Republic of Niger has confirmed its support for the Dasa Project. Niger President Tiani and the Council of Ministers issued the confirmation on Aug. 15. We are pleased to see that the government...
Redhill Biopharma's Shares Jump Premarket on Positive Study Results for Opaganib
Redhill Biopharma's Shares Jump Premarket on Positive Study Results for Opaganib
Aug 19, 2024
07:44 AM EDT, 08/19/2024 (MT Newswires) -- Redhill Biopharma ( RDHL ) said Monday that it achieved positive results from multiple in vivo studies conducted by RedHill's partner, Apogee Biotechnology Corporation, supporting the potential clinical use of opaganib for the prevention and therapy of Type 2 diabetes and other obesity-related disorders. Opaganib treatment reduced weight gain and restored glucose tolerance...
Copyright 2023-2026 - www.financetom.com All Rights Reserved